NCT02975206 Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02846181 A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405 Status COMPLETED Phase PHASE1
NCT02793843 Ondansetron vs Ondansetron Plus Dexamethasone for Relieving Intrathecal Morphine Side Effects After C-section Status COMPLETED Phase NA
NCT02769910 Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch Status COMPLETED Phase PHASE1/PHASE2
NCT02671162 Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus Status COMPLETED Phase PHASE2
NCT02654483 Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients Status COMPLETED Phase PHASE2
NCT02653703 L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain Status COMPLETED Phase NA
NCT02650076 A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects Status COMPLETED Phase PHASE1
NCT02639052 Itch Relieving Effect of Botox: a Study in Healthy Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT02558738 Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations Status COMPLETED Phase N/A
NCT02475447 Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02432508 Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis Status UNKNOWN Phase NA
NCT02247648 Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy Status TERMINATED Phase PHASE2
NCT02229929 Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus Status COMPLETED Phase PHASE2
NCT02174419 Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis Status COMPLETED Phase PHASE2/PHASE3
NCT02143973 Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus Status COMPLETED Phase PHASE2/PHASE3
NCT02143648 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus Status COMPLETED Phase PHASE2/PHASE3